Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Didik Setiawan
Observed name:
Setiawan, Didik
Institution:
Muhammadiyah University Purwokerto
Observed institution:
Muhammadiyah University Purwokerto
ORCID:
0000-0001-9104-548X
Observed ORCID:
0000-0001-9104-548X
OpenAlex ID:
A5040324741
Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis
2023
·
Sudewi Mukaromah Khoirunnisa
, Fithria Dyah Ayu Suryanegara
, et al.
·
Frontiers in Pharmacology
·
9
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
2024
·
Sudewi Mukaromah Khoirunnisa
, Fithria Dyah Ayu Suryanegara
, et al.
·
PharmacoEconomics - Open
·
7
PDF
Costs analysis of radiotherapy for breast cancer in Indonesia: a comparison between reimbursement tariffs and actual costs
2025
·
Fithria Dyah Ayu Suryanegara
, Deni Iskandar
, et al.
·
BMC Health Services Research
·
4
PDF
The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia
2023
·
Didik Setiawan
, Andi Nurul Annisa
, et al.
·
Value in Health Regional Issues
·
4
PDF
Cost of illness of breast cancer in Indonesia in 2024: an analysis from the payer perspective
2026
·
Sudewi Mukaromah Khoirunnisa
, Didik Setiawan
·
Pharmacy Reports
·
1
PDF
The Use of DLBS3233 Bioactive Fraction in Type 2 Diabetes Mellitus Management in Indonesia: A Cost-Effectiveness Analysis of Real-World Evidence
2025
·
Didik Setiawan
, Raymond R Tjandrawinata
, et al.
·
INDONESIAN JOURNAL OF PHARMACY
·
1
PDF
Ee14 Cost-effectiveness and Budget Impact Analysis of Dual Her2 Blockade in High-risk Her2-positive Early Breast Cancer in Indonesia Perspective
2026
·
Alex B. Koro
, Nina Lianawati
, et al.
·
Value in Health Regional Issues
Pengaruh Pelayanan Informasi Obat (PIO) terhadap Penurunan Intensitas Nyeri pada Pasien Swamedikasi di Banyumas
2026
·
Thariq Ahmad Thorir
, Alfarid Kurnialandi
, et al.
·
JFIOnline
PDF
Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer
2025
·
Devi Andiani Putri
, Didik Setiawan
, et al.
·
PHARMACY Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
Cost-Effectiveness Analysis of ERACS Compared to Non-ERACS at Hospital
2024
·
Balqis Hisyam Saleh Basleman
, Susiyadi Susiyadi
, et al.
·
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
PDF
Identifikasi DRPs dan Analisis Biaya Terkait Peresepan Antibiotik dalam Besaran Kapitasi di Puskesmas Kota Cirebon-Indonesia
2024
·
Rizka Rahmania
, Didik Setiawan
, et al.
·
PHARMACY Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
Show more works
View as search
Works count:
13
Citation count:
26
H-index:
4
I10-index:
Year
Topic
Type
